首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Deposits from Creams Containing 20% (w/w) Urea and Suppression of Crystallization (Part 3): Novel Analytical Methods Based on Raman Spectroscopy for the Characterization of Deposits and Deposition Phenomena of Creams Containing 20% (w/w) Urea
【24h】

Deposits from Creams Containing 20% (w/w) Urea and Suppression of Crystallization (Part 3): Novel Analytical Methods Based on Raman Spectroscopy for the Characterization of Deposits and Deposition Phenomena of Creams Containing 20% (w/w) Urea

机译:包含20%(w / w)尿素的乳膏中的沉积物和结晶的抑制作用(第3部分):基于拉曼光谱的新型分析方法,用于表征包含20%(w / w)尿素的乳膏的沉积物和沉积现象

获取原文
           

摘要

In drug formulations for external application, variations in the state of pharmaceutical agents within the base formulation may affect the transfer of agents to the skin. Here, we use Raman spectroscopic methods to acquire more detailed information on the state of the active pharmaceutical ingredients within an externally applied formulation. The combination of wide-field Raman spectroscopy with an experimental method in which drug formulations are applied to glass surfaces provided a new method for characterizing the state of pharmaceutical agents within drug formulations. Here, we demonstrate the usefulness of this new method, called application to glass–wide-field Raman spectroscopy (AG-WRS). In addition to allowing rapid and easy wide-field observations, the use of WRS allows Raman imaging in a manner that is insensitive to variations in the thickness of the formulations applied to sample slides. We consider two types of urea-compound creams with different crystal deposition rates, using AG-WRS to characterize the post-application time-evolving state of deposited crystals. Differences in the base pharmaceutical produce different spectra for the deposits, indicating that the deposits differ in composition and structure. In addition, we use microscopic laser Raman measurements to demonstrate that the process of crystal formulation differs significantly for formulations with different compositions. Our results demonstrate that the combination of AG-WRS with existing analytical techniques such as powder X-ray diffraction or thermal analysis yields more detailed and timely post-application information on the state of pharmaceuticals in external application. We believe this will be a valuable analytical tool for future studies related to the development of external application.
机译:在用于外部应用的药物制剂中,基础制剂内的药物状态的变化会影响药物向皮肤的转移。在这里,我们使用拉曼光谱法获取有关外部应用制剂中活性药物成分状态的更多详细信息。宽视野拉曼光谱与将药物制剂应用于玻璃表面的实验方法相结合,提供了一种表征药物制剂中药物状态的新方法。在这里,我们演示了这种新方法的有用性,这种方法称为“应用于玻璃宽场拉曼光谱(AG-WRS)”。除了可以快速,轻松地进行大范围观察之外,WRS的使用还可以使拉曼成像的方式对应用于样品载玻片的制剂厚度变化不敏感。我们使用AG-WRS来表征两种具有不同晶体沉积速率的脲化合物乳膏,以表征沉积后晶体的应用后时间演变状态。基础药物的差异会产生不同的沉积物光谱,表明沉积物的成分和结构不同。另外,我们使用显微激光拉曼测量来证明晶体配方的过程对于具有不同组成的配方有显着差异。我们的结果表明,将AG-WRS与现有的分析技术(例如粉末X射线衍射或热分析)相结合,可以得到有关外部应用中药物状态的更详细,及时的应用后信息。我们相信,这将是与外部应用程序开发相关的未来研究的宝贵分析工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号